網頁名稱:
Postmarket Drug Safety Information for Patients and Providers
http://www.fda.gov/cder/DrugSafety.htm
網頁簡介:
Postmarket Drug Safety Information for Patients and Provider 是美國 FDA 新設置的一個藥物安全資訊專屬網頁,匯整了FDA以及其他政府官方網站相關網頁的連結,成為藥品上市後安全資訊取得的單一連結入口,提供病人與健康照護者更透明而即時的藥品安全資訊獲取來源,也協助醫藥人員在病人用藥處方上有更好的藥品評估與決策建議,類別包括了Drug Labeling ,Risk Evaluation and Mitigation Strategies (REMS) ,Studies and Clinical Trials of Approved Products Required by FDA or Agreed to by the Application Holder ,Registries and Clinical Trials ,Latest Safety Information ,Reporting Problems to the FDA ,Warnings and Recalls ,Regulations and Guidance Documents ,Using Medicines Safely ,Consumer Articles on Drug Safety ,General Health Information 等等,詳細連結敬請參考官方網站.
相關新聞:
FDA Posts New Drug-Safety Information Web Page
http://www.medscape.com/viewarticle/582118
全站熱搜
留言列表
